US Stock MarketDetailed Quotes

NRIX Nurix Therapeutics

Watchlist

20.020
+0.010+0.05%

Trading Aug 8 09:36 ET

1.29BMarket Cap-6856P/E (TTM)

Nurix Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)May 31, 2024

(Q1)Feb 29, 2024

(FY)Nov 30, 2023

(Q4)Nov 30, 2023

(Q3)Aug 31, 2023

(Q2)May 31, 2023

(Q1)Feb 28, 2023

(FY)Nov 30, 2022

(Q4)Nov 30, 2022

(Q3)Aug 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-114.98%-39.71M

13.42%-41.95M

49.09%-81.37M

170.32%26.69M

11.18%-41.13M

43.89%-18.47M

-13.66%-48.45M

-89.42%-159.81M

-22.79%-37.96M

-54.50%-46.31M

Net income from continuing operations

-83.49%-44.55M

-1.93%-41.52M

20.19%-143.95M

10.19%-41.96M

19.09%-36.98M

46.53%-24.28M

4.23%-40.73M

-53.90%-180.36M

-23.91%-46.72M

-58.52%-45.71M

Operating gains losses

----

6,077.78%556K

--12K

--448K

--40K

--56K

-92.97%9K

--0

Depreciation and amortization

22.74%4.09M

22.26%3.89M

26.33%13.65M

23.71%3.76M

17.26%3.38M

26.63%3.33M

41.15%3.18M

77.70%10.81M

88.63%3.04M

79.48%2.89M

Other non cash items

----

--201K

--0

Change In working capital

-12.04%-5.94M

45.14%-10.21M

205.78%20.12M

3,160.35%58.82M

-40.04%-14.78M

-319.02%-5.3M

-107.72%-18.62M

-308.73%-19.02M

-617.16%-1.92M

-36.74%-10.56M

-Change in receivables

----

--0

--2M

----

354.45%6M

--0

-Change in prepaid assets

-92.11%169K

171.79%1.17M

295.52%2.14M

-136.07%-417K

377.69%2.04M

214,300.00%2.14M

-7.46%-1.63M

79.90%-1.09M

93.31%1.16M

85.87%-735K

-Change in payables and accrued expense

-49,468.42%-9.38M

140.94%2.66M

-37.42%4.74M

222.28%7.73M

481.06%3.5M

-99.76%19K

-90.15%-6.51M

-3.04%7.57M

-43.51%2.4M

-71.83%602K

-Change in other current liabilities

8.31%-1.63M

-11.98%-1.46M

-28.68%-6.27M

-11.41%-1.33M

-64.10%-1.86M

16.73%-1.78M

-219.12%-1.3M

5.31%-4.87M

56.05%-1.19M

-28.96%-1.13M

-Change in other working capital

186.47%4.91M

-37.04%-12.59M

173.28%19.51M

1,287.02%50.84M

-77.21%-16.47M

39.81%-5.68M

-153.70%-9.18M

-286.86%-26.63M

-218.87%-4.28M

-0.43%-9.29M

Cash from discontinued investing activities

Operating cash flow

-114.98%-39.71M

13.42%-41.95M

49.09%-81.37M

170.32%26.69M

11.18%-41.13M

43.89%-18.47M

-13.66%-48.45M

-89.42%-159.81M

-22.79%-37.96M

-54.50%-46.31M

Investing cash flow

Cash flow from continuing investing activities

-399.03%-131.07M

121.02%35.51M

151.13%68.3M

-126.13%-14.37M

136.11%22.78M

1,019.85%43.83M

-59.86%16.07M

125.12%27.2M

250.61%55.01M

-415.71%-63.08M

Net PPE purchase and sale

-79.35%-1.94M

-26.66%-2.88M

31.39%-8.4M

-0.78%-2.59M

28.06%-2.46M

61.28%-1.08M

34.42%-2.28M

-116.29%-12.24M

-197.56%-2.57M

-83.27%-3.42M

Net investment purchase and sale

-387.53%-129.13M

109.30%38.4M

94.47%76.7M

-120.47%-11.79M

142.30%25.23M

2,372.82%44.91M

-57.83%18.35M

138.45%39.44M

261.45%57.57M

-475.52%-59.66M

Cash from discontinued investing activities

Investing cash flow

-399.03%-131.07M

121.02%35.51M

151.13%68.3M

-126.13%-14.37M

136.11%22.78M

1,019.85%43.83M

-59.86%16.07M

125.12%27.2M

250.61%55.01M

-415.71%-63.08M

Financing cash flow

Cash flow from continuing financing activities

950,908.00%237.75M

9.66%1.62M

-97.25%3.22M

105.19%7K

-98.52%1.7M

-94.21%25K

-0.47%1.48M

-23.84%117.19M

-127.00%-135K

7,336.02%115.41M

Net common stock issuance

----

--0

----

-87.08%19.4M

--0

----

Proceeds from stock option exercised by employees

704.00%201K

9.66%1.62M

-96.71%3.22M

105.19%7K

-98.23%1.7M

-94.21%25K

-0.47%1.48M

2,525.29%97.79M

-127.00%-135K

6,086.02%96.01M

Cash from discontinued financing activities

Financing cash flow

950,908.00%237.75M

9.66%1.62M

-97.25%3.22M

105.19%7K

-98.52%1.7M

-94.21%25K

-0.47%1.48M

-23.84%117.19M

-127.00%-135K

7,336.02%115.41M

Net cash flow

Beginning cash position

47.12%50.71M

-15.06%55.53M

-19.08%65.38M

-10.84%43.21M

41.06%59.86M

-56.74%34.47M

-19.08%65.38M

-32.41%80.79M

-67.20%48.46M

-77.47%42.43M

Current changes in cash

163.82%66.98M

84.42%-4.81M

36.13%-9.85M

-27.16%12.32M

-376.51%-16.65M

168.16%25.39M

-2,681.55%-30.9M

60.20%-15.42M

125.28%16.92M

114.82%6.02M

End cash Position

96.61%117.69M

47.12%50.71M

-15.06%55.53M

-10.84%43.21M

41.06%59.86M

-56.74%34.47M

-19.08%65.38M

-67.20%48.46M

Free cash flow

-113.01%-41.64M

11.62%-44.84M

47.83%-89.77M

159.49%24.1M

12.34%-43.59M

45.25%-19.55M

-10.04%-50.73M

-91.11%-172.05M

-27.53%-40.52M

-56.19%-49.73M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)May 31, 2024	(Q1)Feb 29, 2024	(FY)Nov 30, 2023	(Q4)Nov 30, 2023	(Q3)Aug 31, 2023	(Q2)May 31, 2023	(Q1)Feb 28, 2023	(FY)Nov 30, 2022	(Q4)Nov 30, 2022	(Q3)Aug 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-114.98%-39.71M	13.42%-41.95M	49.09%-81.37M	170.32%26.69M	11.18%-41.13M	43.89%-18.47M	-13.66%-48.45M	-89.42%-159.81M	-22.79%-37.96M	-54.50%-46.31M
Net income from continuing operations	-83.49%-44.55M	-1.93%-41.52M	20.19%-143.95M	10.19%-41.96M	19.09%-36.98M	46.53%-24.28M	4.23%-40.73M	-53.90%-180.36M	-23.91%-46.72M	-58.52%-45.71M
Operating gains losses	----	----	6,077.78%556K	--12K	--448K	--40K	--56K	-92.97%9K	--0	--0
Depreciation and amortization	22.74%4.09M	22.26%3.89M	26.33%13.65M	23.71%3.76M	17.26%3.38M	26.63%3.33M	41.15%3.18M	77.70%10.81M	88.63%3.04M	79.48%2.89M
Other non cash items	----	----	----	----	----	----	----	--201K	--0	--0
Change In working capital	-12.04%-5.94M	45.14%-10.21M	205.78%20.12M	3,160.35%58.82M	-40.04%-14.78M	-319.02%-5.3M	-107.72%-18.62M	-308.73%-19.02M	-617.16%-1.92M	-36.74%-10.56M
-Change in receivables	----	----	--0	--2M	----	----	----	354.45%6M	--0	--0
-Change in prepaid assets	-92.11%169K	171.79%1.17M	295.52%2.14M	-136.07%-417K	377.69%2.04M	214,300.00%2.14M	-7.46%-1.63M	79.90%-1.09M	93.31%1.16M	85.87%-735K
-Change in payables and accrued expense	-49,468.42%-9.38M	140.94%2.66M	-37.42%4.74M	222.28%7.73M	481.06%3.5M	-99.76%19K	-90.15%-6.51M	-3.04%7.57M	-43.51%2.4M	-71.83%602K
-Change in other current liabilities	8.31%-1.63M	-11.98%-1.46M	-28.68%-6.27M	-11.41%-1.33M	-64.10%-1.86M	16.73%-1.78M	-219.12%-1.3M	5.31%-4.87M	56.05%-1.19M	-28.96%-1.13M
-Change in other working capital	186.47%4.91M	-37.04%-12.59M	173.28%19.51M	1,287.02%50.84M	-77.21%-16.47M	39.81%-5.68M	-153.70%-9.18M	-286.86%-26.63M	-218.87%-4.28M	-0.43%-9.29M
Cash from discontinued investing activities
Operating cash flow	-114.98%-39.71M	13.42%-41.95M	49.09%-81.37M	170.32%26.69M	11.18%-41.13M	43.89%-18.47M	-13.66%-48.45M	-89.42%-159.81M	-22.79%-37.96M	-54.50%-46.31M
Investing cash flow
Cash flow from continuing investing activities	-399.03%-131.07M	121.02%35.51M	151.13%68.3M	-126.13%-14.37M	136.11%22.78M	1,019.85%43.83M	-59.86%16.07M	125.12%27.2M	250.61%55.01M	-415.71%-63.08M
Net PPE purchase and sale	-79.35%-1.94M	-26.66%-2.88M	31.39%-8.4M	-0.78%-2.59M	28.06%-2.46M	61.28%-1.08M	34.42%-2.28M	-116.29%-12.24M	-197.56%-2.57M	-83.27%-3.42M
Net investment purchase and sale	-387.53%-129.13M	109.30%38.4M	94.47%76.7M	-120.47%-11.79M	142.30%25.23M	2,372.82%44.91M	-57.83%18.35M	138.45%39.44M	261.45%57.57M	-475.52%-59.66M
Cash from discontinued investing activities
Investing cash flow	-399.03%-131.07M	121.02%35.51M	151.13%68.3M	-126.13%-14.37M	136.11%22.78M	1,019.85%43.83M	-59.86%16.07M	125.12%27.2M	250.61%55.01M	-415.71%-63.08M
Financing cash flow
Cash flow from continuing financing activities	950,908.00%237.75M	9.66%1.62M	-97.25%3.22M	105.19%7K	-98.52%1.7M	-94.21%25K	-0.47%1.48M	-23.84%117.19M	-127.00%-135K	7,336.02%115.41M
Net common stock issuance	----	----	--0	--0	--0	----	----	-87.08%19.4M	--0	----
Proceeds from stock option exercised by employees	704.00%201K	9.66%1.62M	-96.71%3.22M	105.19%7K	-98.23%1.7M	-94.21%25K	-0.47%1.48M	2,525.29%97.79M	-127.00%-135K	6,086.02%96.01M
Cash from discontinued financing activities
Financing cash flow	950,908.00%237.75M	9.66%1.62M	-97.25%3.22M	105.19%7K	-98.52%1.7M	-94.21%25K	-0.47%1.48M	-23.84%117.19M	-127.00%-135K	7,336.02%115.41M
Net cash flow
Beginning cash position	47.12%50.71M	-15.06%55.53M	-19.08%65.38M	-10.84%43.21M	41.06%59.86M	-56.74%34.47M	-19.08%65.38M	-32.41%80.79M	-67.20%48.46M	-77.47%42.43M
Current changes in cash	163.82%66.98M	84.42%-4.81M	36.13%-9.85M	-27.16%12.32M	-376.51%-16.65M	168.16%25.39M	-2,681.55%-30.9M	60.20%-15.42M	125.28%16.92M	114.82%6.02M
End cash Position	96.61%117.69M	47.12%50.71M	-15.06%55.53M	-15.06%55.53M	-10.84%43.21M	41.06%59.86M	-56.74%34.47M	-19.08%65.38M	-19.08%65.38M	-67.20%48.46M
Free cash flow	-113.01%-41.64M	11.62%-44.84M	47.83%-89.77M	159.49%24.1M	12.34%-43.59M	45.25%-19.55M	-10.04%-50.73M	-91.11%-172.05M	-27.53%-40.52M	-56.19%-49.73M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall